|
|
Rare Genomics
Rare Genomics Institute empowers patient communities to accelerate research by helping fund and create personalized research projects based on individuals with rare diseases. Their first initiative is to sequence the genomes of these patients. To do this, they provide three innovative services. First, a micro-funding website: an online fundraising platform and social network that helps patient communities raise funds. Second, a researcher network: access to top genomics researchers who are willing to sequence and analyze these patients. Third, a clinical network: connecting patients with clinicians and genetic counselors who will help interpret and translate the individualized research findings.
Jimmy Lin
Jimmy is the lead computational biologist for the ground-breaking cancer genome sequencing efforts from the Vogelstein Lab at Johns Hopkins. Their sequencing of the first 100+ cancer exomes in 5 different tissue types has helped lay the foundation for a revolution in cancer genomics. Jimmy is a MD/PhD student at Johns Hopkins School of Medicine and MAR student at Reformed Theological Seminary, writing on a “Systematic Theology of Medicine”. Prior to this, he finished a MHS in Bioinformatics at the Johns Hopkins Bloomberg School of Public Health and studied molecular biology and cognitive science at Yale University.
Scott Taing
Scott is the data curator for the modENCODE chromatin group through the Lui Lab of the Dana Farber Cancer Institute and Harvard School of Public Health. His interests are developing systems and tools to scale the analysis and visualization of genomics data. He did graduate level work at Johns Hopkins and Nanjing University and holds a bachelors degree from Yale University.
|
